Trademarkia Logo

Canada

C$
RapiSafe
ADVERTISED

on 7 May 2025

Last Applicant/ Owned by

SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.

21st Floor, Snibe Building,No.23, Jinxiu East Road,Jinsha Community, Kengzi Street,Pingshan District, ShenzhenGuangdong Province

CN

Serial Number

2165623 filed on 14th Dec 2021

Correspondent Address

COASTAL TRADEMARK SERVICES LIMITED

301-543 Granville StreetVancouver

BRITISH COLUMBIA

CA

V6C1X8

RapiSafe

Trademark usage description

pharmaceutical preparations, namely, pharmaceutical preparations for the functional analysis of blood coagulation and fibrinolysis; pharmaceutical pre Read More

Classification Information


Class [005]
Pharmaceutical preparations, namely, pharmaceutical preparations for the functional analysis of blood coagulation and fibrinolysis; pharmaceutical preparations for the quantitative and qualitative detection of substances in human serum, plasma and body fluids; chemico-pharmaceutical preparations for pharmaceutical purposes, namely, chemico-pharmaceutical preparations for pharmaceutical purposes for the functional analysis of blood coagulation and fibrinolysis; chemico-pharmaceutical preparations for pharmaceutical purposes for the quantitative and qualitative detection of substances in human serum, plasma and body fluids; medicated serums used for the functional analysis of blood coagulation and fibrinolysis; medicated serums used for the quantitative and qualitative detection of analytes in human serum, plasma and body fluids; medicines for use in serum therapy, namely, medicines for serum therapy for functional analysis of blood coagulation and fibrinolysis; medicines for use in serum therapy for the quantitative and qualitative detection of substances in human serum, plasma and body fluids; biological preparations for medical purposes, namely, for blood coagulation and anticoagulation, fibrinolysis and anti-fibrinolysis functional analysis, and for quantitative and qualitative detection of various analytes in human serum, plasma and body fluids; chemical preparations for pharmaceutical purposes, namely, chemical preparations for pharmaceutical purposes for the functional analysis of blood coagulation and fibrinolysis; chemical preparations for pharmaceutical purposes for the quantitative and qualitative detection of substances in human serum, plasma and body fluids; chemical preparations for medical purposes, namely, for blood coagulation and anticoagulation, fibrinolysis and anti-fibrinolysis functional analysis, and quantitative and qualitative detection of various analytes in human serum, plasma and body fluids; chemical preparations for medical purposes for the quantitative and qualitative detection of substances in human serum, plasma and body fluids; enzymes for medical purposes, namely, for blood coagulation and anticoagulation, fibrinolysis and anti-fibrinolysis functional analysis, and quantitative and qualitative detection of various analytes in human serum, plasma and body fluids; diagnostic enzyme preparations for medical laboratory use; preparations for pharmaceutical purposes, namely, preparations for pharmaceutical purposes made of trace elements that are found in the human body for the functional analysis of blood coagulation and fibrinolysis; preparations for pharmaceutical purposes made of trace elements that are found in the human body for the quantitative and qualitative detection of substances in human serum, plasma and body fluids; amino acids for medical purposes; cultures of microorganisms for medical use, namely bacterial cultures for the treatment of intestinal diseases; chemical preparations for the diagnosis of pregnancy; diagnostic preparations for medical laboratory use; reagents for use in diagnostic tests for medical purposes; reagents for use in diagnostic tests for veterinary purposes; reagent paper for medical purposes; diagnostic biomarker reagents for medical purposes; veterinary preparations for treatment of intestinal bacteria; medicines for veterinary purposes for treatment of intestinal bacteria; biological preparations for veterinary purposes for treatment of intestinal bacteria; chemical preparations for veterinary purposes for treatment of intestinal bacteria; enzymes for veterinary purposes for treatment of intestinal bacteria; enzyme preparations for veterinary purposes for treatment of intestinal bacteria; diagnostic preparations for veterinary purposes for treatment of intestinal bacteria; reagent paper for veterinary purposes.


Classification kind code

11

Mark Details


Serial Number

2165623

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 48
on 29th Jun 2023
Agent Changed
Submitted for opposition 22
on 24th May 2023
Search Recorded
Submitted for opposition 20
on 24th May 2023
Examiner's First Report
Submitted for opposition 223
on 24th May 2023
Total Provisional Refusal
Submitted for opposition 256
on 12th Dec 2022
Notification of Possible Opposition Sent
Submitted for opposition 257
on 10th Feb 2022
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 9th Feb 2022
Created
Submitted for opposition 31
on 9th Feb 2022
Formalized
Submitted for opposition 30
on 14th Dec 2021
Filed
Submitted for opposition 228
on 14th Dec 2021
International Registration

This website uses cookies

We use cookies to ensure you get the best experience. Check our Privacy Policy and Terms & Conditions.
Manage cookies

Manage cookies

You can choose to enable or disable some or all of these cookies but disabling some of them may affect your browsing experience.

Advertisement

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously

Analytics

Analytical cookies are used to understand how visitors interact with the website.

Functional

Functional cookies help perform certain functionalities like collecting feedback, and other third-party features.

Performance

Performance cookies are used to understand and analyze the key performance indexes of the website.